Schedule 13G ownership disclosure

N/A

COMMON STOCK · CUSIP: 14179K101

Event date: 2025-03-31

Filing-level shares
597,682
Percent of class
1.3%
  • T. Rowe Price Associates, Inc.

    Shares: 597,682 · Class: 1.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-25-000379
Form type
SCHEDULE 13G/A
Filer
CARGO Therapeutics, Inc.
CIK
CIK 1966494
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub